SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Jack London

PatientJack London
Date of birth1987-01-12
IdentifiersMRN HR-ET010-SYN; SSN (made up) 000-10-4482
Document date2026-08-04
AuthorEleanor Whitcombe-Ibe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for establishing care for tiredness and ankle swelling, with high blood pressure and abnormal kidney tests, and heavy drinking found at the visit: kidney, liver and alcohol tests, AUDIT and DSM-5-TR assessment, withdrawal planning, mood and safety, his writing schedule, and a nephrology consultation. [S]

Objective

Sodium: 139 mmol/L; Potassium: 4.6 mmol/L; Bicarbonate (total CO2): 22 mmol/L; Urea nitrogen: 28 mg/dL (high); Creatinine: 1.98 mg/dL (high); Glucose: 94 mg/dL; eGFR (CKD-EPI 2021): 43 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 240 mg/g (high); Uric acid: 8.4 mg/dL (high); Calcium: 9.2 mg/dL; Phosphate: 3.8 mg/dL; Parathyroid hormone, intact: 74 pg/mL (high); Hemoglobin: 13.6 g/dL; MCV: 101 fL (high); Platelets: 182 10*3/uL; AST: 68 U/L (high); ALT: 41 U/L; GGT: 186 U/L (high); Albumin: 4.1 g/dL; Total bilirubin: 0.9 mg/dL; INR: 1; PEth (alcohol marker): 410 ng/mL (high); HbA1c: 5.4%; Total cholesterol: 214 mg/dL (high); HDL cholesterol: 58 mg/dL; LDL cholesterol (calculated): 128 mg/dL; Triglycerides: 140 mg/dL; AUDIT: 27; PHQ-9: 9; GAD-7: 7. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-08-04Body height173cmS
2026-08-04Body weight84.2kgS
2026-08-04Body mass index (BMI) [Ratio]28.1kg/m2S
2026-08-04Systolic blood pressure158mm[Hg]S
2026-08-04Diastolic blood pressure98mm[Hg]S
2026-08-04Heart rate92/minS
2026-08-04Respiratory rate16/minS
2026-08-04Body temperature36.8CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-04Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-08-04Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-08-04Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/L22-29 mmol/LNormalS
2026-08-04Urea nitrogen [Mass/volume] in Serum or Plasma28mg/dL7-20 mg/dLHighS
2026-08-04Creatinine [Mass/volume] in Serum or Plasma1.98mg/dL0.74-1.35 mg/dLHighS
2026-08-04Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-08-04Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M43mL/min/{1.73_m2}45 to 59 is G3a; 30 to 44 is G3bLowS
2026-08-04Albumin/Creatinine [Mass Ratio] in Urine240mg/gBelow 30 mg/g A1; 30 to 300 A2; above 300 A3HighS
2026-08-04Urate [Mass/volume] in Serum or Plasma8.4mg/dL4-8 mg/dLHighS
2026-08-04Calcium [Mass/volume] in Serum or Plasma9.2mg/dL8.6-10.3 mg/dLNormalS
2026-08-04Phosphate [Mass/volume] in Serum or Plasma3.8mg/dL2.5-4.5 mg/dLNormalS
2026-08-04Parathyrin.intact [Mass/volume] in Serum or Plasma74pg/mL15-65 pg/mLHighS
2026-08-04Hemoglobin [Mass/volume] in Blood13.6g/dL13-17 g/dLNormalS
2026-08-04MCV [Entitic mean volume] in Red Blood Cells by Automated count101fL80-100 fLHighS
2026-08-04Platelets [#/volume] in Blood by Automated count18210*3/uL150-400 10*3/uLNormalS
2026-08-04Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma68U/L10-40 U/LHighS
2026-08-04Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma41U/L9-46 U/LNormalS
2026-08-04Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma186U/L8-61 U/LHighS
2026-08-04Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
2026-08-04Bilirubin.total [Mass/volume] in Serum or Plasma0.9mg/dL0.2-1.2 mg/dLNormalS
2026-08-04INR in Platelet poor plasma by Coagulation assay1{INR}0.9-1.1NormalS
2026-08-04Phosphatidylethanol [Mass/volume] in Blood410ng/mLBelow 20 ng/mL abstinence or light drinking; above 200 heavy drinkingHighS
2026-08-04Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
2026-08-04Cholesterol [Mass/volume] in Serum or Plasma214mg/dL<=199 mg/dLHighS
2026-08-04Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=40 mg/dLNormalS
2026-08-04Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation128mg/dL<=129 mg/dLNormalS
2026-08-04Triglyceride [Mass/volume] in Serum or Plasma140mg/dL<=149 mg/dLNormalS
2026-08-04Total score [AUDIT]27{score}S
2026-08-04Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-08-04Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen 500 mg oral tablet twice daily, bought over the counter at full strength and taken most days for about two years for knee and back pain; stopped at intakeOne tablet by mouth twice a day, self-directedOral route2024-08-01 to 2026-08-04stoppedS
Losartan 50 mg oral tablet once dailyOne tablet by mouth every morningOral route2026-08-04 to 2026-09-15completedS
Chlordiazepoxide 25 mg oral capsule, fixed five-day taper for alcohol withdrawal (four capsules on day 1, three on day 2, two on day 3, one on days 4 and 5), dispensed for five days only, with a daily telephone checkUp to one capsule four times a day on day 1, tapering to one a day by day 4; stop after day 5; no alcohol or drivingOral route2026-08-04 to 2026-08-08completedS
Thiamine 100 mg oral tablet once dailyOne tablet by mouth dailyOral route2026-08-04activeS
Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for pain, no more than 2,000 mg in a day, in place of naproxenOne to two tablets by mouth every six hours as needed; no more than four tablets a dayOral route2026-08-04activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Tiredness, ankle swelling and high blood pressure (158/98 mmHg) with a raised creatinine (1.98 mg/dL, eGFR 43) and albumin in the urine (240 mg/g), found at intake; a creatinine of 1.7 mg/dL at an insurance examination about fourteen months ago, by his account; chronicity and cause under evaluation with a nephrology consultationactiveconfirmed R94.4S — Synthetic presenting problem anchored to the documented kidney damage found in 1913; superseded when the consultation staged chronic kidney disease.
Alcohol use disorder, severe (seven DSM-5-TR criteria): a bottle of whisky or more most days for years, a morning drink to steady his hands, failed attempts to cut down, and drinking despite knowing it harms his health; AUDIT 27; PEth 410 ng/mLactiveconfirmed F10.20S — Synthetic modern diagnosis anchored to his own published account of heavy drinking; the criteria, scores and amounts are synthetic and are not a claim about his real drinking.
Daily self-directed naproxen for knee and back pain for about two years, stopped at intake; acetaminophen in its placeactiveconfirmed Z79.1S — Synthetic medication history; the joint pain is anchored to the documented rheumatism of 1914, which is not given a diagnosis.
Cigarette smoking, about ten a day; not ready to stop while he stops drinkingactiveconfirmed F17.210S — Synthetic tobacco use; a physician-author's suggestion of heavy tobacco use is recorded only as a retrospective claim.

Assessment

Plan of Treatment